Cargando…
Isolated thrombosis after COVID-19 vaccination: case series
BACKGROUND: Data regarding thrombosis after COVID-19 vaccination are scarce. METHODS: Clinical and laboratory data were collected from all patients who developed thrombosis within 4 weeks of receiving the Pfizer or Oxford/AstraZeneca vaccine. None had a COVID-19-positive swab. RESULTS: Seventeen pat...
Autores principales: | Al-Ahmad, Mona, Al Rasheed, Mona, Altourah, Lulwa, Rodriguez-Bouza, Tito, Shalaby, Neveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734543/ https://www.ncbi.nlm.nih.gov/pubmed/34993889 http://dx.doi.org/10.1007/s12185-021-03285-6 |
Ejemplares similares
-
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination
por: Al-Ahmad, Mona, et al.
Publicado: (2022) -
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca‐Oxford COVID‐19 vaccine
por: Al‐Ahmad, Mona, et al.
Publicado: (2021) -
Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells
por: Hasan, Amal, et al.
Publicado: (2022) -
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
por: Abu-Raddad, Laith J, et al.
Publicado: (2021) -
High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
por: Kerbikov, Oleg, et al.
Publicado: (2021)